Transcept Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

TSPT 3.05 +0.03 (0.99%)
price chart
Drug Delivery Partnering Terms and Agreements
Sacramento Bee - Jun 13, 2013
Big pharma drug delivery partnering company profiles Abbott Actavis Inc (formerly Watson Pharmaceuticals) Actavis (merged with Watson Pharmaceuticals Oct 2012) Actelion Allergan Amgen Astellas AstraZeneca Baxter International Bayer Biogen Idec ... Tel ...
Related articles »  
TOP GAINERS Pre Market Today � Novavax Inc, FuelCell Energy, Clovis ...
Pentagon Post - Jun 6, 2013
Price-to-earnings ratio is 26.65. Market capitalization: $173.46 million. Transcept Pharmaceuticals Incorporated (NASDAQ: TSPT) currently trades at $3.17, up 5.1 percent in Pre-Market with 15,020 share volume.
Related articles »  
Transcept Pharmaceuticals Inc Announces Phase Two Clinical Trial Of TO-2061 As Adjunctive Therapy For Obsessive Compulsive Disorder Did Not Meet Primary Endpoint
Reuters Key Development - Dec 21, 2012
Transcept Pharmaceuticals, Inc. Appoints Leone Patterson As Vice President And Chief Financial Officer
Reuters Key Development - Jun 26, 2012
Transcept Pharmaceuticals, Inc. Prices Public Offering Of Common Stock
Reuters Key Development - Apr 26, 2012
Transcept Pharmaceuticals, Inc. Announces Proposed Public Offering
Reuters Key Development - Apr 25, 2012
Transcept Pharmaceuticals, Inc. Announces FDA Approval Of Intermezzo C-IV
Reuters Key Development - Nov 23, 2011
Transcept Pharmaceuticals, Inc. Announces Plan to Resubmit Intermezzo New Drug Application Following Meeting With U.S. Food & Drug Administration
Reuters Key Development - Sep 14, 2011
Transcept Pharmaceuticals, Inc. Announces FDA Response to Proposal in Support of Intermezzo New Drug Application
Reuters Key Development - Sep 14, 2011
Transcept Pharmaceuticals, Inc. Announces Plans to Reduce Expenses by Decreasing Staff Following Complete Response Letter from FDA on Intermezzo New Drug Application; Sees Charges In Q3 2011
Reuters Key Development - Jul 16, 2011

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
To see all exchange delays, please see disclaimer.

©2013 Google - Google Home - Blog - Help - Report a Problem - Privacy Policy - Terms of Service